Live Breaking News & Updates on Federal Joint Committee

Stay updated with breaking news from Federal joint committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aflibercept in AMD: no proof of added benefit

Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG)… ....

Efficiency In Health Care , German Institute For Quality , Medicinal Products , German Institute , Health Care , Federal Joint Committee ,

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2024 - advancing the company with renewed vigor

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024. Business highlights Viatris ....

United States , Switzerland General , South Korea , Republic Of , Northern Ireland , United Kingdom , New Zealand , Hong Kong , Martine Clozel , Neurocrine Biosciences , Jean Paul Clozel , Alberto Gimona , Andrewc Weiss , Nxera Pharma , Daridorexant Nxera Pharma , Sosei Heptares , Daridorexant Simcere , Jean Yves Chatelan , Journal Of Sleep Research , Drug Enforcement Administration , European Union , Day Center , Drug Administration , Research Development , Healthcare Unitedhealth Group , European Commission ,

Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor

Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Switzerland General , Northern Ireland , United Kingdom , Republic Of , New Zealand , South Korea , Hong Kong , Daridorexant Simcere , Sosei Heptares , Jean Yves Chatelan , Alberto Gimona , Andrewc Weiss , Nxera Pharma , Daridorexant Nxera Pharma , Jean Paul Clozel , Martine Clozel , Neurocrine Biosciences , Daridorexant Us Department Of Defense , Committee For Medicinal Products Human Use , Head Of Investor Relations Corporate Communications , Health Technology Agency , Idorsia Ltd , Head Of Global Clinical Development Idorsia , Viatris Inc , Us Department Of Defense ,

GNW-Adhoc: Idorsia announces financial results for the first quarter 2024 - advancing the company with renewed vigor

GNW-Adhoc: Idorsia announces financial results for the first quarter 2024 - advancing the company with renewed vigor
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United States , Northern Ireland , United Kingdom , Switzerland General , South Korea , Jean Yves Chatelan , Jean Paul Clozel , Alberto Gimona , Nxera Pharma , Drug Administration , Head Of Global Clinical Development Idorsia , Idorsia Ltd , Enforcement Administration , European Union , Health Technology Agency , National Institute For Health , Research Development , Us Congress , Committee For Medicinal Products , Viatris Inc , European Commission , Scottish Medicines Consortium , Healthcare Unitedhealth Group , Paul Clozel , Chief Executive Officer , Viatris Deal ,

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Kristen Kluska , Joseph Schwartz , Anupam Rama , Andrew Faughnan , Simon Harford , Ellen Rosenberg , Sebastien Martel , Jeff Castelli , Mitchell Goldman , Fabry Pompe , Ellie Merle , Bradley Campbell , Cantor Fitzgerald , Exchange Commission , Morgan Stanley , Amicus Therapeutics Inc , Biggest Publicly Traded Ai Companies , European Union , Development Officer , Amicus Therapeutics , Call Transcript May , Amicus Therapeutic First Quarter , Results Conference Call , Vice President ,